The CRN 2026 Partner Program Guide includes computing IT vendor partner programs that are designated 5-Star programs.
Q4 2025 Earnings Call February 25, 2026 8:30 AM ESTCompany ParticipantsKevin Grant - Vice President of Investor Relations ...
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd.
The CRN 2026 Partner Program Guide includes data center IT vendor partner programs that are designated 5-Star programs.
Foreign Exchange Rate Assumption -- A GBP/USD planning rate of 1.35 for 2026, representing a $0.02 headwind on constant ...
Equillium (EQ) remains a 'Hold' as it advances EQ504 for ulcerative colitis, with phase 1 trial initiation targeted for mid-2026. Company's Multi-Cytokine Platform enables selective cytokine targeting ...
FDA Approval for Pediatric Indication -- LINZESS received U.S. FDA approval in November 2025 for IBS-C patients aged 7-17, ...
Plan maximizes free cash flow and strengthens balance sheetAccelerates return of capital, including a 10% dividend increase, under an enhanced ...
On inflation, immigration, tariffs and matters of war and peace, the president presented a frequently distorted account as he claimed a “turnaround for the ages.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results